tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

IRON Stock Latest News

Disc Medicine price target lowered to $88 from $110 at Wedbush
The FlyDisc Medicine price target lowered to $88 from $110 at Wedbush
5d ago
IRON
Disc Medicine price target lowered to $125 from $153 at Cantor Fitzgerald
PremiumThe Fly
Disc Medicine price target lowered to $125 from $153 at Cantor Fitzgerald
5d ago
IRON
Disc Medicine price target lowered to $75 from $120 at Morgan Stanley
PremiumThe Fly
Disc Medicine price target lowered to $75 from $120 at Morgan Stanley
5d ago
IRON
Disc Medicine price target lowered to $110 from $125 at Stifel
PremiumThe Fly
Disc Medicine price target lowered to $110 from $125 at Stifel
5d ago
IRON
Disc Medicine price target lowered to $100 from $120 at BMO Capital
PremiumThe Fly
Disc Medicine price target lowered to $100 from $120 at BMO Capital
5d ago
IRON
Disc Medicine Addresses FDA Rejection of Bitopertin Filing
PremiumCompany AnnouncementsDisc Medicine Addresses FDA Rejection of Bitopertin Filing
5d ago
8K
IRON
Disc Medicine: Long‑Term Value Intact as Bitopertin Shifts to Lower‑Risk Traditional Approval Path
Premium
Ratings
Disc Medicine: Long‑Term Value Intact as Bitopertin Shifts to Lower‑Risk Traditional Approval Path
5d ago
IRON
Disc Medicine move down Friday ‘fair’ after bitopertin CRL, says Wells Fargo
Premium
The Fly
Disc Medicine move down Friday ‘fair’ after bitopertin CRL, says Wells Fargo
6d ago
IRON
Disc Medicine Receives FDA Complete Response on Bitopertin
PremiumCompany Announcements
Disc Medicine Receives FDA Complete Response on Bitopertin
9d ago
8K
IRON
Disc Medicine off lows after saying FDA issue ‘readily addressable’
PremiumThe Fly
Disc Medicine off lows after saying FDA issue ‘readily addressable’
9d ago
IRON
Disc Medicine down 32% to $49 after confirming rejection letter from FDA
PremiumThe Fly
Disc Medicine down 32% to $49 after confirming rejection letter from FDA
9d ago
IRON
Disc Medicine confirms complete response letter from FDA for bitopertin
PremiumThe Fly
Disc Medicine confirms complete response letter from FDA for bitopertin
9d ago
IRON
Disc Medicine says issue raised by FDA ‘readily addressable’
PremiumThe FlyDisc Medicine says issue raised by FDA ‘readily addressable’
9d ago
IRON
Disc Medicine extends decline after volatility halt
Premium
The Fly
Disc Medicine extends decline after volatility halt
9d ago
IRON
Disc Medicine plunges after FDA posts complete response letter for bitopertin
Premium
The Fly
Disc Medicine plunges after FDA posts complete response letter for bitopertin
9d ago
IRON
Disc Medicine drops 21% to $56.53 in afternoon plunge
PremiumThe Fly
Disc Medicine drops 21% to $56.53 in afternoon plunge
9d ago
IRON
Iron Planet Inc. trading halted, volatility trading pause
PremiumThe Fly
Iron Planet Inc. trading halted, volatility trading pause
9d ago
IRON
Disc Medicine: Differentiated EPP Therapy and Asymmetric FDA Catalyst Support Buy Rating
PremiumRatings
Disc Medicine: Differentiated EPP Therapy and Asymmetric FDA Catalyst Support Buy Rating
19d ago
IRON
FDA Calendar: These Are the Remaining Drug Approvals Anticipated This Month
PremiumMarket News
FDA Calendar: These Are the Remaining Drug Approvals Anticipated This Month
24d ago
AQST
IRON
Disc Medicine: Bitopertin’s Accelerated Approval Path and FDA Timing Support Buy Rating and $118 Target
PremiumRatingsDisc Medicine: Bitopertin’s Accelerated Approval Path and FDA Timing Support Buy Rating and $118 Target
1M ago
IRON
Reported timing of Disc Medicine review date a positive, says Morgan Stanley
Premium
The Fly
Reported timing of Disc Medicine review date a positive, says Morgan Stanley
1M ago
IRON
Disc Medicine falls -6.8%
Premium
The Fly
Disc Medicine falls -6.8%
1M ago
IRON

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >